Profiles

Keywords
Last Name
Institution
 Back to Profile

Marta Batus

Concepts (115)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
8
2016
296
2.320
 Why?
Carcinoma, Non-Small-Cell Lung
12
2018
352
1.700
 Why?
Lung Neoplasms
12
2018
717
1.410
 Why?
Molecular Targeted Therapy
3
2013
38
1.210
 Why?
Antibodies, Monoclonal
4
2016
305
0.970
 Why?
Sarcoma
3
2019
92
0.870
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2019
378
0.820
 Why?
Immunotherapy
2
2013
67
0.720
 Why?
Medical Oncology
1
2016
37
0.720
 Why?
Chemoradiotherapy
4
2019
70
0.670
 Why?
ErbB Receptors
4
2018
76
0.590
 Why?
Melanoma
1
2013
60
0.570
 Why?
Bone Neoplasms
1
2013
107
0.540
 Why?
Carcinoma, Squamous Cell
4
2018
188
0.360
 Why?
Drug Resistance, Neoplasm
2
2018
69
0.320
 Why?
Neoplasm Recurrence, Local
2
2016
181
0.310
 Why?
Receptor, IGF Type 1
2
2013
18
0.290
 Why?
Quinazolines
2
2012
27
0.270
 Why?
Humans
20
2019
26729
0.270
 Why?
Prognosis
6
2018
920
0.270
 Why?
Neoplasm Staging
7
2016
479
0.240
 Why?
Adenocarcinoma
3
2018
227
0.230
 Why?
Retrospective Studies
10
2019
2780
0.230
 Why?
Inflammation Mediators
1
2018
81
0.200
 Why?
Palliative Care
2
2015
104
0.190
 Why?
Female
15
2019
15965
0.190
 Why?
Treatment Outcome
7
2019
3364
0.190
 Why?
Male
14
2019
15601
0.190
 Why?
Gene Dosage
2
2012
27
0.170
 Why?
Protein Kinase Inhibitors
2
2018
61
0.170
 Why?
Neoplasm Metastasis
2
2013
138
0.170
 Why?
Aged
10
2019
8906
0.160
 Why?
Survival Rate
4
2018
418
0.160
 Why?
Radiotherapy, Conformal
1
2014
24
0.150
 Why?
Cancer Vaccines
1
2013
19
0.150
 Why?
Angiogenesis Inhibitors
1
2013
25
0.150
 Why?
Neoplasms
1
2016
236
0.150
 Why?
Mutation
2
2018
409
0.150
 Why?
Forecasting
1
2013
128
0.140
 Why?
Adult
6
2019
8754
0.140
 Why?
Weight Gain
1
2012
59
0.140
 Why?
Middle Aged
10
2019
10097
0.140
 Why?
Follow-Up Studies
5
2018
1872
0.140
 Why?
PTEN Phosphohydrolase
1
2011
13
0.140
 Why?
Phosphatidylinositol 3-Kinases
1
2011
48
0.130
 Why?
Survival Analysis
4
2015
372
0.130
 Why?
Gene Amplification
1
2010
28
0.130
 Why?
Child, Preschool
1
2013
752
0.120
 Why?
Xanthine Dehydrogenase
1
2010
7
0.120
 Why?
Pyrimidines
1
2010
27
0.120
 Why?
Gastrointestinal Stromal Tumors
1
2010
12
0.120
 Why?
Rectal Neoplasms
1
2010
26
0.120
 Why?
Young Adult
2
2016
1937
0.120
 Why?
Adolescent
2
2016
2397
0.120
 Why?
Gene Expression Regulation, Neoplastic
1
2010
117
0.120
 Why?
Piperazines
1
2010
87
0.110
 Why?
United States
1
2016
2104
0.110
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2008
6
0.110
 Why?
Child
1
2013
1393
0.110
 Why?
Clinical Trials as Topic
1
2010
370
0.110
 Why?
Chromosomes, Human, Pair 10
1
2007
6
0.100
 Why?
Chromosomes, Human, Pair 3
1
2007
7
0.100
 Why?
Chromosomes, Human, Pair 1
1
2007
13
0.100
 Why?
Receptor, ErbB-2
1
2007
40
0.100
 Why?
Carcinoma, Large Cell
2
2018
18
0.090
 Why?
Animals
2
2013
4851
0.090
 Why?
Neoadjuvant Therapy
2
2019
62
0.080
 Why?
Kaplan-Meier Estimate
2
2017
203
0.080
 Why?
Carboplatin
2
2015
48
0.080
 Why?
Etoposide
2
2015
64
0.080
 Why?
Paclitaxel
2
2015
73
0.080
 Why?
Aged, 80 and over
4
2018
4537
0.070
 Why?
Breast Neoplasms
1
2007
404
0.070
 Why?
Cohort Studies
2
2015
1650
0.060
 Why?
Mesna
1
2019
4
0.060
 Why?
Ifosfamide
1
2019
16
0.060
 Why?
Organ Sparing Treatments
1
2019
12
0.050
 Why?
Arm
1
2019
51
0.050
 Why?
Doxorubicin
1
2019
74
0.050
 Why?
Leg
1
2019
46
0.050
 Why?
Proteomics
1
2018
47
0.050
 Why?
Leukocyte Count
1
2017
90
0.050
 Why?
Taxoids
1
2016
16
0.050
 Why?
Tomography, X-Ray Computed
2
2014
823
0.050
 Why?
Lymphocytes
1
2017
107
0.050
 Why?
Deoxycytidine
1
2016
46
0.050
 Why?
Body Weight
1
2017
156
0.050
 Why?
Radiation Pneumonitis
1
2015
4
0.050
 Why?
Hemoptysis
1
2015
9
0.050
 Why?
Esophagitis
1
2015
11
0.040
 Why?
Cough
1
2015
12
0.040
 Why?
Neutrophils
1
2017
125
0.040
 Why?
Chest Pain
1
2015
20
0.040
 Why?
Dyspnea
1
2015
25
0.040
 Why?
Chemoradiotherapy, Adjuvant
1
2015
20
0.040
 Why?
Radiation Injuries
1
2015
41
0.040
 Why?
Disease-Free Survival
1
2015
230
0.040
 Why?
Mobility Limitation
1
2015
81
0.040
 Why?
Radiotherapy Dosage
1
2014
145
0.040
 Why?
Diet
1
2015
169
0.040
 Why?
Radiotherapy Planning, Computer-Assisted
1
2014
73
0.040
 Why?
Prospective Studies
1
2018
1590
0.040
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2011
10
0.030
 Why?
Activities of Daily Living
1
2015
418
0.030
 Why?
Benzamides
1
2010
11
0.030
 Why?
Immunohistochemistry
1
2012
478
0.030
 Why?
Colectomy
1
2010
33
0.030
 Why?
Quality of Life
1
2015
534
0.030
 Why?
Combined Modality Therapy
1
2011
453
0.030
 Why?
Biopsy
1
2010
267
0.030
 Why?
Smoking
1
2010
170
0.030
 Why?
Signal Transduction
1
2012
524
0.030
 Why?
Fatal Outcome
1
2008
71
0.030
 Why?
Risk Assessment
1
2011
719
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2007
118
0.020
 Why?
Batus's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (115) concept(s)
_
Co-Authors Expand Description
See all (24) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department